Ovasave, a Hub71 FemTech startup focused on fertility and hormonal health, has raised $1.2 million in its pre-seed round from a mix of regional and international investors.
The round was led by PlusVC, Annex Investments, and 25 Madison, a New York-based firm, with additional backing from strategic angel investors and prominent family offices based in the UAE and Saudi Arabia.
The $1.2 million capital raised will be used to support regional expansion across the GCC, scale corporate partnerships, and launch the next phase of Ovasave’s mobile app, which will include menstrual cycle tracking, symptom monitoring, access to care, and AI-driven treatment protocols.
The raise comes as the UAE accelerates national reforms in healthcare and women’s rights, offering a timely window for FemTech innovation.
Ovasave is registered with the Department of Health – Abu Dhabi and supported by Abu Dhabi’s global tech ecosystem, Hub71, further aligning it with the nation’s broader digital and preventive health strategies.
Majd Abu Zant, Co-founder of Ovasave, said that, “Abu Dhabi’s focus on innovation, healthcare, and entrepreneurship has created a competitive environment for founders and investors alike. As an Abu Dhabi-based startup supported by Hub71, Ovasave has benefited from a strong regulatory framework, access to capital, and proximity to regional decision-makers. It’s the right environment to build and scale high-impact ventures, and from here, we are expanding into Saudi Arabia and the wider MENA region.”
“There is a critical need for timely intervention in women’s health, particularly around fertility and hormonal health. This funding marks a crucial step in our mission to disrupt women’s health and expand access to fertility and hormonal care across the region,” noted Torkia Mahloul, Co-founder and CEO of Ovasave.
According to the statement, with a $1.2 million pre-seed round now closed, Ovasave is expanding its operations to Saudi Arabia this summer, with broader regional growth across the MENA region being part of its three-year expansion strategy.
